Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index48
i10-index78
Publications284
Citations19,077

Grants

8 total · 5 active

NIH #R01CA312637

Restoring anti-tumor immunity in chromosomally unstable tumors

Active
Amount
$600K–$700K
Period
2026-06-02 → 2031-05-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01AI199896

Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)

Active
Amount
$800K–$900K
Period
2026-05-01 → 2031-04-30
PIs
2

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #U54CA274506

Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis

Active
Amount
$300K–$400K
Period
2023-09-19 → 2028-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 5 active

NIH #R01CA312637

Restoring anti-tumor immunity in chromosomally unstable tumors

Active
Amount
$600K–$700K
Period
2026-06-02 → 2031-05-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01AI199896

Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)

Active
Amount
$800K–$900K
Period
2026-05-01 → 2031-04-30
PIs
2

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #U54CA274506

Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis

Active
Amount
$300K–$400K
Period
2023-09-19 → 2028-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01CA280414

Multi-cellular interactions defining the human brain metastatic niche

Active
Amount
$700K–$800K
Period
2023-05-01 → 2028-04-30
PIs
2

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01CA266446

The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy

Active
Amount
$400K–$500K
Period
2022-09-01 → 2027-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R37CA258829

Mechanisms of liver metastasis and associated resistance to immunotherapy

Amount
$400K–$500K
Period
2021-03-09 → 2026-02-28
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R21CA263381

Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools.

Amount
$200K–$300K
Period
2021-07-08 → 2023-06-30
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #K08CA222663

Dissecting mechanisms of immunotherapy resistance in melanoma patients

Amount
$100K–$200K
Period
2017-09-14 → 2022-08-31
PIs
1

Awarded at DANA-FARBER CANCER INST

Recent Public Signals

  1. New paper: Codebase for "Spatiotemporal lineage tracing reveals the dynamic spatial architecture of tumour growth and metastasis" (Zenodo (CERN European Organization for Nuclear Research))2026-07-08
  2. New NIH award: Restoring anti-tumor immunity in chromosomally unstable tumors2026-06-02
  3. New preprint: Targeting CD73-A <sub>2a</sub> R-Mediated Adenosine Signaling at the Tumor-Immune Interface Overcomes Radioresistance2026-05-29

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-31

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-2379-6702

Professor Insights

Career Trajectory